跳至主要内容
临床试验/NCT05349162
NCT05349162已完成不适用

Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children

Paris Cardiovascular Research Center (Inserm U970)0 个研究点目标入组 131 人开始时间: 2003年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
131
主要终点
Number of patients with implantable cardioverter defibrillator system dysfunction (lead dysfunction requiring reintervention)

研究概览

简要总结

This observational study included all patients <18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • ICD implantation
  • Age < 18 years

排除标准

  • Absence of patient's consent

结局指标

主要结局

Number of patients with implantable cardioverter defibrillator system dysfunction (lead dysfunction requiring reintervention)

时间窗: up to 15 years

Number of patients in each group (epicardial and transvenous implantable cardioverter defibrillator) with an implantable cardioverter defibrillator dysfunction (dysfunction of at least one lead requiring reintervention) at the end of the follow-up

次要结局

未报告次要终点

研究者

发起方
Paris Cardiovascular Research Center (Inserm U970)
申办方类型
Other Gov
责任方
Sponsor

相似试验